Morphologies of CART-RNA Nanoparticles for mRNA Delivery

Study Background and Research Question

The delivery of mRNA therapeutics relies on the efficient encapsulation, protection, and cytosolic release of polyanionic nucleic acids. While lipid nanoparticles (LNPs) have achieved clinical prominence—most notably for mRNA vaccines—synthetic polymer-based systems are increasingly explored as alternatives, offering tunable physicochemical properties. Amphiphilic Charge-Altering Releasable Transporters (CARTs) have emerged as a promising class of single-component, synthetic vectors capable of self-assembly with RNA. However, the structural factors influencing the morphology and efficacy of these assemblies remain poorly understood. The reference study (Hurst et al., ACS Nano) addresses a central question: how do CART chemical structure and oligonucleotide cargo dictate the internal architecture of CART-RNA nanoparticles, and what are the implications for rational vector design?

Key Innovation from the Reference Study

The core innovation lies in the detailed characterization of the internal morphologies of CART-RNA assemblies using advanced structural techniques. The authors employed cryogenic electron microscopy (CryoEM, CryoET), small-angle neutron scattering (SANS), and small-angle X-ray scattering (SAXS) to visualize and quantify the structure of nanoparticles formed through the co-assembly of mRNA or siRNA with synthetic cationic amphiphilic block copolymers (CARTs). The study reveals that low-molar-mass CARTs (≤10,000 g/mol) with tailored block lengths form nanoparticles exhibiting bicontinuous, disordered internal domains—a feature largely governed by both the polymer architecture and the nature of the nucleic acid cargo. This level of structural control provides new avenues for optimizing mRNA delivery and translation efficiency assays.

Methods and Experimental Design Insights

The authors synthesized a series of CARTs by sequential ring-opening polymerization of lipid and cationic morpholinone monomers, carefully varying block lengths and side-chain identities. The resulting amphiphiles were characterized by NMR and SEC, confirming precise control over molecular weight and composition. To probe RNA complexation, the team mixed CARTs with mRNA or siRNA, allowing spontaneous assembly into nanoparticles.

Structural analysis was performed using:

• CryoEM and CryoET: Provided direct visualization of nanoparticle morphology at nanometer resolution, revealing internal organization.
• SANS and SAXS: Quantified domain spacings and assessed the degree of internal order in the assemblies.

By systematically varying both the cationic and lipophilic block lengths and the nature of the RNA cargo, the study established structure–function relationships governing assembly morphology.

Core Findings and Why They Matter

A major finding is that low-molar-mass CARTs (≤10,000 g/mol) co-assemble with RNA into nanoparticles featuring disordered bicontinuous internal morphologies. These structures are composed of interpenetrating lipid-rich and aqueous coacervate domains, with characteristic domain spacings in the 6–8 nm range. The presence of RNA is crucial: it not only promotes nanoparticle formation but also drives the emergence of the bicontinuous morphology, suggesting a direct role for polynucleotide cargo in templating internal structure (Hurst et al.).

Conversely, when higher-molar-mass CARTs (≥28,000 g/mol) were employed, the resulting assemblies lacked bicontinuous order and instead formed aggregates of 10–20 nm particles. This shift was attributed to changes in the balance of hydrophilic and hydrophobic block lengths, supporting the hypothesis that precise polymer tuning is essential for achieving morphologies optimal for gene delivery.

These structural insights have practical implications for mRNA delivery and translation efficiency assays. Bicontinuous domains may facilitate improved encapsulation, protection, and cytosolic release of mRNA, which is critical for efficient gene expression and the suppression of RNA-mediated innate immune activation. Understanding the relationship between vector structure and function lays the groundwork for designing next-generation gene delivery systems that surpass the limitations of conventional LNPs.

Comparison with Existing Internal Articles

Several recent internal reviews have highlighted the importance of dual-fluorescence mRNA constructs and advanced capping strategies in evaluating mRNA delivery efficiency and immune evasion. For example, one analysis discusses how dual-labeled reporter mRNA enables real-time tracking of delivery and translation, and another (internal article) focuses on multiplexed translation assays. The current reference study complements these approaches by providing a mechanistic, structural understanding of how carrier morphology—determined by polymer architecture—affects mRNA encapsulation and delivery outcomes. By correlating morphological features with delivery potential, these combined insights enable researchers to design and validate more effective mRNA delivery systems, whether using fluorescently labeled mRNA or advanced polymeric vectors.

Limitations and Transferability

Although the study establishes clear links between CART architecture, RNA cargo, and nanoparticle morphology, several limitations warrant consideration. First, the work predominantly employs in vitro structural characterization; direct correlations between nanoparticle morphology and in vivo delivery efficacy or immune response require further validation. Additionally, the focus on single-component synthetic amphiphiles, while advantageous for mechanistic clarity, may not fully capture the complexity of clinical formulations that combine multiple excipients. Finally, the observed structure–function relationships are specific to the CART chemistries and RNA cargos tested; transferability to other mRNA sequences, lengths, or chemical modifications (such as 5-methoxyuridine incorporation) remains to be established.

Protocol Parameters

• CART synthesis: Lipid and cationic block lengths can be systematically varied; typical low-molar-mass block copolymers are ≤10,000 g/mol for bicontinuous morphologies.
• RNA complexation: Mix CARTs with mRNA or siRNA at defined N/P ratios (charge ratio of amine groups to phosphate groups), typically between 2:1 and 10:1, to enable spontaneous nanoparticle self-assembly.
• Structural analysis: For morphology determination, employ CryoEM and SAXS/SANS to resolve domain spacings (6–8 nm typical for bicontinuous structures).
• Cargo considerations: The morphology is sensitive to both the type (mRNA vs. siRNA) and physical properties of the RNA cargo.
• Workflow suggestion: When adapting these systems to fluorescently labeled or chemically modified mRNA (e.g., 5-moUTP, Cap 1), confirm compatibility with the chosen polymer and verify nanoparticle morphology by imaging and scattering methods.

Research Support Resources

For researchers aiming to evaluate mRNA delivery and translation efficiency in the context of advanced nanoparticle vectors, reagents such as EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) provide a dual-fluorescence reporter system incorporating enhanced green fluorescent protein coding sequence and Cy5 label. This construct enables direct visualization of mRNA uptake and protein expression, supporting studies on nanoparticle morphology, delivery efficiency, and suppression of RNA-mediated innate immune activation. Combined with the mechanistic insights from the reference study, such tools facilitate rigorous evaluation and optimization of novel gene delivery platforms.